Locametz side effects, by duration, gender and age (a phase IV clinical study of FDA data)

Summary:

Side effects are reported by people who take Locametz (gallium ga-68 gozetotide). Common side effects include bone marrow failure among males.

The phase IV clinical study is created by eHealthMe based on 48 reports from the FDA, and is updated regularly.

What is Locametz?

Locametz has active ingredients of gallium ga-68 gozetotide. eHealthMe is studying from 48 Locametz users. Check the latest studies of Locametz.



On Aug, 08, 2026

48 people who take Locametz and have side effects are studied.

Locametz side effects.

What are the common side effects of Locametz, by gender? *:

female:

n/a

male:

  1. Bone marrow failure
  2. Alanine aminotransferase increased
  3. Agitation (state of anxiety or nervous excitement)
  4. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
  5. Amylase increased
  6. Cystitis (inflammation of the wall of the bladder)
  7. Dry mouth
  8. Dyspnoea (difficult or laboured respiration)
  9. Gastroenteritis (inflammation of stomach and intestine)
  10. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)

What are the common side effects of Locametz, by age (0-1 to 60+) *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Alanine aminotransferase increased
  2. Amylase increased
  3. Infusion site extravasation (flow of (blood or lymph) from infusion site)

60+:

  1. Anaemia (lack of blood)
  2. Dysphagia (a condition in which swallowing is difficult or painful)
  3. Influenza like illness
  4. Intestinal obstruction
  5. Meningitis (inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges)
  6. Skin infection
  7. Ventricular tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart)
  8. Visual impairment
  9. Agitation (state of anxiety or nervous excitement)
  10. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)

What are the common side effects of Locametz, by the time people have been on the drug (< 1 month to 10+ years)? *:

< 1 month:

  1. Bone marrow failure
  2. Haemorrhage intracranial (bleeding within the skull)

1 - 6 months:

n/a

6 - 12 months:

  1. Infection

1 - 2 years:

n/a

2 - 5 years:

n/a

5 - 10 years:

n/a

10+ years:

n/a

not specified:

  1. Ventricular tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart)
  2. Visual impairment
  3. Agitation (state of anxiety or nervous excitement)
  4. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
  5. Amylase increased
  6. Bone marrow failure
  7. Cystitis (inflammation of the wall of the bladder)
  8. Dry mouth
  9. Dyspnoea (difficult or laboured respiration)
  10. Fatigue (feeling of tiredness)

* Approximation only. Some reports may have incomplete information.

Do you take Locametz?

- Personalize this study to your gender and age
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.



How the study uses the data?

The study is based on gallium ga-68 gozetotide (the active ingredients of Locametz) and Locametz (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.

Related studies are listed below in case you need more information:

Alternative drugs to, pros and cons of Locametz:

All Locametz side effects from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: